CMP (Rs) 166 Upside/ (Downside) (%) (1) Bloomberg Ticker Market Cap. (Rs bn) 125 Free Float (%) 37 Shares O/S (mn) 726

Transcription

1 2QFY18 Result Update November 8, 217 Market Cap. (Rs bn) 125 Free Float 37 Shares O/S (mn) 726 PSB Recap A Big Positive; but Earnings to Remain Tepid With lower fresh slippages (lowest in last 8 quarters) and remarkable improvement on asset quality front, (UBI) has positively surprised market in 2QFY18. The Management chosen to strengthen the balance sheet over profitability by increasing Provision Coverage Ratio (PCR) to 49.1% (sans technically w/o loans) and 56.1% (with technically w/o loans) in 2QFY18 compared to 44.3%/51.1% in 1QFY18 and 43.3%/5.4%, respectively in 2QFY17. As a result the provisioning expenses increased by 119.4% YoY and 18.6% QoQ to Rs35.6bn, for which the Bank incurred the first ever net loss of Rs15.3bn in current credit business cycle. However, the Bank s loan book grew by 4.5% QoQ and 9.7% YoY, while its average CASA ratio improved to 34.1% in 2QFY18 compared to 33.9% in 1QFY18. Management Commentary & Guidance The Bank expects loan book, deposit and CASA ratio to grow by 8-1%, 7-8% and 35%, respectively in FY18. It expects slippages ratio and credit cost at ~4.4% and ~3.3% respectively for FY18. The Bank envisages gradual improvement in stressed assets, as most of the recognition has already been done. Its total stressed loan (GNPA + Std. Restructured) stood at 14.1% in total loan book. The Bank s SMA-2 balance substantially declined to 4.4% of loan book (Rs13.6bn) compared to 6.8% of loan book in 1QFY18 and 5.4% in 2QFY17. Though the Bank is yet to receive the RBI s final report on Annual Supervisory Assessment for FY17, the Management does not expect any major divergence. The Management highlighted that the strategy of growing Retail, Agriculture and MSME business is moving in right direction (contribution of RAM stood at 54.1% vs. 53.8% in 4QFY17) led by improvement in retail liability as well as retail loan. Credit cost is expected to increase marginally, as the Bank is looking forward to further improve its PCR to >6% in coming period from the current level of 56.1%. Notably, the Management expects higher upgrade and recovery in current fiscal to support PCR. Outlook & Valuation UBI is one of the most capital-starved public sector banks. Its CET1 stood at 7% in Sep 17, which is barely few bps above minimum regulatory requirement. We expect the Bank can be one of the major beneficiaries of recently announced mega PSB recapitalisation plan, as higher recapitalisation will help the Bank to come out of the capital insuiciency situation and return strongly on the growth path. However, the Bank may continue to witness elevated level of credit cost, which may keep its earnings and return ratios subdued over next 3-6 quarters. Hence, we continue to maintain our recommendation on the stock with an unrevised Target Price of Rs164 based on 1.1x FY19E Adjusted book value. Key Financials E FY19E NII 83,131 89,33 97, ,971 PPP 56,426 74,31 75,96 92,729 PAT 13,516 5,552 (9,57) 12,11 EPS (Rs) (12.5) 16.5 P/E (x) (13.3) 1. Adj. BV (Rs) P/Adj. BV (x) Gross NPA Net NPA Avg. ROA.3.1 (.2).2 Avg. ROE (3.9) 5. Share price 1 mth 3 mth 12 mth Absolute performance Relative to Nifty Shareholding Pattern Jun 17 Sep'17 Promoter Mutual Funds Insurance Companies Foreign Portfolio Investors Others Total Year Stock Price Performance Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Note: * CMP as on Nov. 7, 217 Research Analyst : Asutosh Kumar Mishra Contact : asutosh.mishra@relianceada.com 1

2 Risks to the View Downside Risk: Any major slowdown in economy may adversely impact the Bank s asset quality. Upside Risk: Higher than expected business growth and accelerated resolution of the stressed assets. Exhibit 1: Income Statement Analysis 2Q FY18 2Q FY17 % yoy / bps 1Q FY18 % qoq / bps 1H FY18 1H FY17 % yoy / bps Interest on Advance 57,543 58,171 (1.1) 57, , ,86 (.8) YoA - Calculated (83) 8.1 (4) (8) Income on Investment 21,949 21, , ,425 39, Interest on Balances 2,588 2, , ,138 4, Others Interests (78.8) ,71 (74.6) Interest Earned 82,224 82, , ,754 16, Interest Expended 59,17 59,37 (.5) 59,14 (.1) 118, ,51.9 CoF - Calculated (58) 5.4 (15) (5) Net Interest Income 23,27 22, , ,633 43, NIM - Calculated (2) (15) NIM - Reported 2.3 (22) 2 NA NA NA NII as % of Oper. Income (16) (335) Core Fee Income 5,49 4, ,6 (9.4) 11,55 9, Fee Inc. as % of OI (15) Non Core Fee Income 6,683 6, ,87 (17.4) 14,77 12, Non core fee Inc. as % of OI (322) Total Other Income 12,173 11, ,147 (13.9) 26,32 21, Other Inc. as % of OI (427) Operating Income (OI) 35,381 34, ,573 (3.3) 71,953 65, Core Operating Income 28,697 27, , ,183 53, Employees Expenses 8,58 8,736 (7.8) 8,213 (1.9) 16,271 17,326 (6.1) Employees Expn. as % of OI (279) (38) Other Operating Expenses 7,933 7, , ,727 13, Other Opert Exp. as % of OI Total Operating Expenses 15,991 15, ,7 (.1) 31,998 31, Cost to income Ratio (155) (31) Operating Profit (OP) 19,39 18, ,566 (5.7) 39,956 34, Provisions and Conting. 35,547 16, , ,584 29, Pro Burden as % of OP , , ,529 Profit Before Tax (16,157) 1,994 (91.2) 3,529 (557.9) (12,628) 4,715 (367.8) Tax Expenses (85) 227 (473.7) 2,363 (136.) 1,513 1, Eective Tax Rate (614) 67. (6,17) (1) 27.3 (3,924) Net Profit (15,37) 1,767 (966.4) 1,166 (1,413.) (14,141) 3,43 (512.3) EPS (21.9) 2.6 (951.1) 1.7 (1,386.6) (2.2) 5. (54.3) 2

3 Exhibit 2: NIM witnessed improvement in 2QFY18 led by lower cost of funds Exhibit 3: NII growth improved sequentially led by higher share of RAM segments , 24, 22, 2, 18, NII (LHS) NII as % of Avg. Assets Exhibit 4: Other income growth remained subdued led by lower treasury profit 16, 12, 8, 4, Exhibit 5: Operating expenses remained subdued as UBI focused towards contorting other opex 18, 16,5 15, 13,5 12, Other Income OI as % of Operating Income Operating Expenses C/I Ratio Exhibit 6: The Bank frontloaded provision on loans referred to NCLT, which led to sharp surge in PCR Exhibit 7: Higher provisioning and lower operating profit negatively impacted UBI s bottom-line 4, 3, 2, 1, (5) (1) (15) (4.) (8.) (1,2.) Provision Expenses Provision as % of OP PAT (LHS) Growth YoY (RHS) 3

4 Exhibit 8: Balance Sheet Analysis (Rs bn) 2Q FY17 3Q FY17 4Q FY17 1Q FY18 2Q FY18 QoQ % / bps YTD % / bps YoY % / bps Net Worth (3.9) (3.5) (3.6) Deposit 3,615 3,798 3,784 3,758 3, Savings Deposits 96 1,11 1,41 1,48 1, Current Deposits (23.) (15.9) (5.9) CASA Deposit 1,14 1,397 1,33 1,334 1,296 (2.9) (.6) 13.7 Term Deposit 2,474 2,41 2,481 2,424 2, Investments 1,19 1,352 1,121 1,215 1, Advances 2,652 2,627 2,865 2,784 2, Total Business 7,457 7,777 7,77 7,757 8, Avg Int. Earning Assets 3,961 4,252 4,26 4,355 4, Risk Weighted Assets 2,813 2,819 2,912 2,868 2, (.3) 3.2 CAR (79) (57) 3 Tier I Capital (74) (52) (6) Exhibit 9: Loan book growth was driven by RAM and domestic corporate segments Exhibit 1: Deposit growth was led by retail term and saving deposits (Rs bn) (Rs bn) (1) (2) (3.) (.8) (3.9) 3.2 (1.) 9.1 (2.8) (4) (8) (1.) 4.7 (1.2) (.4) (.7) (1) (3.) Incremental loan disbursement (LHS) Adv. Gr. qoq Incremental Deposit Mobilization (LHS) Deposit Gr. qoq (RHS) Exhibit 11: Loan Book Analysis 2Q FY17 3Q FY17 4Q FY17 1Q FY18 2Q FY18 QoQ % / bps YTD % / bps YoY % / bps Agriculture 411,59 47,23 441,24 44,92 429,9 (2.7) (2.8) 4.3 MSME 582,68 57,97 619,13 66,76 622, Large Corporate & Other 1,18,61 999,45 1,16,36 1,17,76 1,8, (2.3) 6.1 Retail Advances 374,92 376,23 43,8 423,57 447, Overseas 264,8 272,71 294,46 294,92 329, Exhibit 12: Loan Book Analysis (% Break Up) 2Q FY17 3Q FY17 4Q FY17 1Q FY18 2Q FY18 QoQ % / bps YTD % / bps YoY % / bps Agriculture (19) (65) (77) MSME (39) (21) (57) Large Corporate & Other (147) (125) Retail Advances Overseas

5 Exhibit 13: Management is targeting average CASA ratio of 34-35% by Mar 18 (Rs bn) 1,6 1, Exhibit 14: PSB recap plan is expected to provide much-needed fillip to UBI on capital front CASA Deposits (LHS) CASA Ratio (RHS) Total CAR Tier I 5

6 Exhibit 15: Asset Quality Analysis 2Q FY17 3Q FY17 4Q FY17 1Q FY18 2Q FY18 QoQ % / bps YTD % / bps YoY % / bps Gross Non Performing Assets 298, ,27 337, , , Fresh Slippages 33,96 32,94 29,51 44,53 26,86 (39.7) (9.) (2.9) Net Non Performing Assets 169, , ,321 27,85 194,794 (6.3) GNP Ratio (28) NNP Ratio (77) NPA Coverage Ratio Restructured Gross Loans 56,36 55,23 56,96 38,57 52, (7.5) (6.5) Restr. Loan as % of Adv (18) (31) Exhibit 16: Slippages declined sequentially during the quarter under review Exhibit 17: Lower fresh slippages along with higher write-o helped the Bank to contain GNE growth , 45, 3, 15, Incremental Gross NPA (LHS) Gross NPA Gr. qoq (RHS) Exhibit 18: PCR improved due to relatively higher provisioning during the quarter Exhibit 19: Lower GNP formation and higher provisioning expenses led to moderation in net NPA formation , 2, 15, 1, 5, Net NPA (LHS) Net NPA Ratio (RHS) 6

7 Profit & Loss Statement (Y/E March, Rs mn) E FY19E Interest Earned 321, ,6 332,647 37,579 Interest Expenditure 238, , , ,68 Net Interest Income 83,131 89,33 97, ,971 Fee Income 4,98 4,687 6,826 8,614 Non Fee Income 32,22 44,959 41,339 46,983 Other Income 36,317 49,646 48,166 55,597 Net Operating Income 119, , ,35 17,568 Core Operating Income 87,229 93,721 14,11 123,585 Employee Expenses 36,993 34,342 37,776 43,65 Other Expenses 26,29 3,36 31,613 34,775 Operating Expenses 63,22 64,378 69,39 77,84 Operating Profit 56,426 74,31 75,96 92,729 Provisions and Contingencies 38,772 7,786 85,19 74,935 Profit Before Tax 17,654 3,515 (9,148) 17,794 Taxes 4,138 (2,38) (91) 5,783 Profit After Tax 13,516 5,552 (9,57) 12,11 Balance Sheet (Y/E March, Rs mn) E FY19E Capital & Liabilities Capital 6,874 6,874 7,264 7,264 Reserves Total 222,38 227, , ,75 Net Worth 228, , , ,97 Deposits 3,427,2 3,783,916 4,15,549 4,557,159 Current deposits 297, , ,78 364,573 Saving deposits 811,326 1,4,724 1,98,234 1,253,219 Term Deposits 2,318,442 2,48,829 2,668,67 2,939,368 Borrowings 39, ,259 67, ,359 Other Liabilities & Provisions 81,273 91,18 83,516 87,291 Total Liabilities 4,46,959 4,527,44 5,26,761 5,611,778 Assets Cash & Cash Equivalents 292, , ,983 47,526 Investments 892,83 1,121,49 1,228,427 1,345,751 Advances 2,673,54 2,864,666 3,194,12 3,593,365 Fixed Assets 39,399 38,944 4,339 41,263 Other Assets 149, ,72 198,99 223,872 Total Assets 4,46,959 4,527,44 5,26,761 5,611,778 7

8 Per Share Data and Valuation Y/E March FY16 FY17E FY18E FY19E No. of Shares (mn) Earnings Per Share (Rs) (12.5) 16.5 Book Value / Share (Rs) ABV/Share (Rs) Dividend Per Share (Rs) Price/ Earnings (x) (13.3) 1. Price/ BV (x) Price/Adjusted BV (x) Key Assumptions Loan Growth Deposit Growth RWA Growth Slippages Ratio Cost of Fund Yield on Fund NIM Other Income Growth (3.) 15.4 Cost to Income Ratio Average Credit Cost Eective Tax Rate 23.4 (58.) Growth Rate Net interest Income (1.5) Other Income (3.) 15.4 Operating Profit (3.1) Provisions Expense (1) PAT (24.1) (58.9) (263.1) (232.6) Risk Weighted Assets Yields / Margins Cost of Funds (CoF) Yield on Advance Yield on funds Net Interest Margin (NIM) Balance Sheet Ratio Credit / Deposit Ratio Incremental C/D Ratio Investment-Deposit Ratio CASA Ratio

9 Asset Quality Gross NPA/Gross Advances Net NPA/Net Advances Provisioning Burden as % of PPP Provisioning Coverage Ratio Slippage ratio Provis. Exp. to Avg. Advance RoA Tree Analysis NII / Avg. Assets 2.2 Core Fee / Avg. Assets Core Rev. / Avg. Assets Ope. Exp. / Avg. Assets Cost to Income Emp. cost / Avg. Assets Oprt. Exp. / Avg. Assets Core OP/ Avg. Assets Trading & Ot/ Avg. Assets OP/ Avg. Assets Provisions / Avg. Assets NPA prov. / Avg. Assets PBT / Avg. Assets.4.1 (.2).3 Tax / Avg. Assets.1 (.) (.).1 Eective Tax Rate 23.4 (58.) RoA.3.1 (.2).2 Leverage (x) RoE (3.9) 5. Capital Adequacy Ratio Total CAR Tier

10 Rating Guides Rating Expected absolute returns over 12 months BUY >1% -5% to 1% REDUCE >-5% Reliance Securities Limited (RSL), the broking arm of Reliance Capital is one of the India s leading retail broking houses. Reliance Capital is amongst India s leading and most valuable financial services companies in the private sector. Reliance Capital has interests in asset management and mutual funds, life and general insurance, commercial finance, equities and commodities broking, wealth management services, distribution of financial products, private equity, asset reconstruction, proprietary investments and other activities in financial services. The list of associates of RSL is available on the website RSL is registered as a Research Analyst under SEBI (Research Analyst) Regulations, 214 General Disclaimers: This Research Report (hereinafter called Report ) is prepared and distributed by RSL for information purposes only. The recommendations, if any, made herein are expression of views and/or opinions and should not be deemed or construed to be neither advice for the purpose of purchase or sale of any security, derivatives or any other security through RSL nor any solicitation or oering of any investment /trading opportunity on behalf of the issuer(s) of the respective security(ies) referred to herein. These information / opinions / views are not meant to serve as a professional investment guide for the readers. No action is solicited based upon the information provided herein. Recipients of this Report should rely on information/data arising out of their own investigations. Readers are advised to seek independent professional advice and arrive at an informed trading/investment decision before executing any trades or making any investments. This Report has been prepared on the basis of publicly available information, internally developed data and other sources believed by RSL to be reliable. RSL or its directors, employees, ailiates or representatives do not assume any responsibility for, or warrant the accuracy, completeness, adequacy and reliability of such information / opinions / views. While due care has been taken to ensure that the disclosures and opinions given are fair and reasonable, none of the directors, employees, ailiates or representatives of RSL shall be liable for any direct, indirect, special, incidental, consequential, punitive or exemplary damages, including lost profits arising in any way whatsoever from the information / opinions / views contained in this Report. Risks: Trading and investment in securities are subject to market risks. There are no assurances or guarantees that the objectives of any of trading / investment in securities will be achieved. The trades/ investments referred to herein may not be suitable to all categories of traders/investors. The names of securities mentioned herein do not in any manner indicate their prospects or returns. The value of securities referred to herein may be adversely aected by the performance or otherwise of the respective issuer companies, changes in the market conditions, micro and macro factors and forces aecting capital markets like interest rate risk, credit risk, liquidity risk and reinvestment risk. Derivative products may also be aected by various risks including but not limited to counter party risk, market risk, valuation risk, liquidity risk and other risks. Besides the price of the underlying asset, volatility, tenor and interest rates may aect the pricing of derivatives. Disclaimers in respect of jurisdiction: The possession, circulation and/or distribution of this Report may be restricted or regulated in certain jurisdictions by appropriate laws. No action has been or will be taken by RSL in any jurisdiction (other than India), where any action for such purpose(s) is required. Accordingly, this Report shall not be possessed, circulated and/ or distributed in any such country or jurisdiction unless such action is in compliance with all applicable laws and regulations of such country or jurisdiction. RSL requires such recipient to inform himself about and to observe any restrictions at his own expense, without any liability to RSL. Any dispute arising out of this Report shall be subject to the exclusive jurisdiction of the Courts in India. Disclosure of Interest: The research analysts who have prepared this Report hereby certify that the views /opinions expressed in this Report are their personal independent views/opinions in respect of the securities and their respective issuers. None of RSL, research analysts, or their relatives had any known direct /indirect material conflict of interest including any long/short position(s) in any specific security on which views/opinions have been made in this Report, during its preparation. RSL s Associates may have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of research report. RSL, its Associates, the research analysts, or their relatives might have financial interest in the issuer company(ies) of the said securities. RSL or its Associates may have received a compensation from the said issuer company(ies) in last 12 months for the brokerage or non brokerage services.rsl, its Associates, the research analysts or their relatives have not received any compensation or other benefits directly or indirectly from the said issuer company(ies) or any third party in last 12 months in any respect whatsoever for preparation of this report. The research analysts has served as an oicer, director or employee of the said issuer company(ies)?: No RSL, its Associates, the research analysts or their relatives holds ownership of 1% or more, in respect of the said issuer company(ies).?: No Copyright: The copyright in this Report belongs exclusively to RSL. This Report shall only be read by those persons to whom it has been delivered. No reprinting, reproduction, copying, distribution of this Report in any manner whatsoever, in whole or in part, is permitted without the prior express written consent of RSL. RSL s activities were neither suspended nor have defaulted with any stock exchange with whom RSL is registered. Further, there does not exist any material adverse order/judgments/ strictures assessed by any regulatory, government or public authority or agency or any law enforcing agency in last three years. Further, there does not exist any material enquiry of whatsoever nature instituted or pending against RSL as on the date of this Report. Important These disclaimers, risks and other disclosures must be read in conjunction with the information / opinions / views of which they form part of. RSL CIN: U6599MH25PLC SEBI registration no. ( Stock Brokers: NSE - INB / INF / INE ; BSE - INB / INF / INE , Depository Participants: CDSL IN-DP IN-DP-NSDL , Research Analyst: INH2384); AMFI ARN No